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Summary 
Neurotropic strains of mouse hepatitis viruses (MHV) such as MHV-A59 (A59) and MHV-4 
(JHMV) cause acute and chronic encephalomyelitis and demyelination in susceptible strains of 
mice and rats. They are widely used as models of human demyelinating diseases such as multiple 
sclerosis  (MS), in which immune mechanisms are thought to participate in the development 
of lesions in the central nervous system (CNS).  The effects of MHV infection on target cell 
functions in the CNS are not well understood, but A59 has been shown to induce the expression 
of MHC class I molecules in glial cells after in vivo and in vitro infection. Changes in class 
I expression in infected cells may contribute to the immunopathogenesis of MHV infection in 
the CNS. In this communication, a large panel of MHV strains was tested for their ability to 
stimulate class I expression in primary astrocytes in vitro. The data show that the more hepatotropic 
strains,  such as MHV-A59, MHV-1, MHV-2, MHV-3, MHV-D, MHV-K, and MHV-NuU, 
were potent inducers of class I expression in astrocytes during acute infection, measured by 
radioimmunoassay. The K b molecule was preferentially expressed over D b. By contrast, JHMV 
and several viral strains derived from it did not stimulate the expression of class I molecules. 
Assays of virus infectivity indicated that the class I-inducing activity did not correlate with the 
ability of the individual viral strain to replicate in astrocytes. However, exposure of the viruses 
or the supernatants from infected astrocytes to ultraviolet light abolished the class I-inducing 
activity, indicating that infectious virus is required for class I expression. These data also suggest 
that class I  expression was induced directly by virus infection, and not by the secretion of a 
soluble  substance  into  the medium by infected astrocytes.  Finally,  analyses  of A59/JHMV 
recombinant viral strains suggest that class I-inducing activity resides in one of the A59 structural 
genes. 
M 
ouse hepatitis  viruses  (MHV) 1 are members of the 
Coronaviridae, which cause gastrointestinal, neurolog- 
ical, and respiratory diseases in a wide variety of mammalian 
species (1-7). Although some MHV strains,  such as A59 and 
MHV-3, can cause both gastrointestinal and neurological dis- 
ease in mice and rats, many tend to induce pathology that 
is restricted to either system, prompting their classification 
as hepatotropic or neurotropic. There has been considerable 
interest in the study of the more neurotropic strains of MHV, 
such as JHMV and A59, because of their ability to produce 
demyelinating lesions that resemble the demyelinating plaques 
observed in the human neurological disease,  multiple scle- 
rosis (MS). In addition, MHV and human coronavirus iso- 
1 Abbreviations  used in thispaper: CNS, central  nervous system;  GFAP, glial 
fibrillary acidic protein; i.c., intracerebral; M, membrane; MHV, mouse 
hepatitis virus; m.o.i., multiplicity  of infection; MS, multiple sclerosis; 
N, nucleocapsid;  p.i., post infection;  S, spike; VSV, vesicular  stomatitis  virus. 
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lates are capable of inducing demyelination in primates (8), 
and coronavirus RNA  and antigen have been detected in 
demyelinating lesions in the brains of MS patients (9,  10). 
As Coronaviridae, all MHV strains are enveloped viruses 
that contain a single-stranded, positive-sense ILNA genome 
of 31-kb that is expressed as 7 or 8 mRNAs encoding both 
structural and nonstructural proteins (11). The structural pro- 
teins have been well characterized, and include the nucleo- 
capsid (N) protein, which interacts with the viral RNA, and 
two envelope glycoproteins, the spike (S) and membrane (M) 
proteins. The S protein forms the virion surface spikes and 
is responsible for binding the cellular MHV receptor, inducing 
cell-to-cell fusion and providing a target for neutralizing an- 
tibodies. It is the least conserved of the structural proteins 
among the MHV strains (12-16).  M  interacts with the N 
protein-R.NA comply, and may be involved in virus assembly. 
It is the most conserved structural protein among the MHV. 
A third envelope glycoprotein, hemagglutinin-esterase (HE), 
has been identified in MHV-S and several JHMV isolates, 
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in the central nervous system (CNS) (11, 17). Nonstructural 
proteins include an RNA-dependent RNA polymerase, and 
three additional proteins that do not appear  to be required 
for viral replication, but whose functions and biological ac- 
tivities have  not been identified. 
After intracerebral (i.c.) inoculation in mice and rats,  the 
parent strains of both JHMV and A59 cause  an acute en- 
cephalomyelitis and demyelination from which  a  varying 
number of animals survive to exhibit chronic demyelination 
(1-7,  11). The severity of the disease varies with the individual 
virus strain and with the age, genetic background, and im- 
mune status of the infected host. The neuropathological fea- 
tures of acute infection can be somewhat distinguished from 
those of chronic disease by a prevalence  of gray matter in- 
volvement in which virus replicates in neurons, oligodendro- 
cytes, and astrocytes to cause extensive CNS damage (18-21). 
In chronic disease, lesions are more prevalent  in the white 
matter and consist of primary demyelination with axonal 
sparing (2, 11). Infectious virus is rarely isolated during chronic 
JHMV disease, though viral RNA can be detected by reverse 
transcriptase (RT)-PCR in the brains of infected mice as late 
as 2 yr post infection (p.i., Fleming, J., personal communi- 
cation). Viral antigen and RNA tend to be restricted to as- 
trocytes in chronic infection (2, 22-25), though there is evi- 
dence that neurons are also affected (25). This pattern of white 
matter involvement is also characteristic of infection with at- 
tenuated or mutant strains of A59 (26,  27) or JHMV (25, 
27-29),  which cause demyelination in the relative absence 
of encephalitis. In vitro, JHMV and A59 cause a lytic infec- 
tion in primary oligodendrocyte cultures that is rapidly self- 
limiting, but both virus strains can establish a productive and 
relatively nonlytic, acute, and long-term chronic infection in 
mixed glial cell cultures and in cultures enriched for astro- 
cytes (30-32).  These data support early reports  that acute 
demyelination is the result of virus-mediated oligodendro- 
cyte death (2,  11), but more importantly, they also suggest 
that the astrocyte plays an important role in acute encepha- 
litis and chronic demyelination. 
Currently, there is very little known about the ability of 
MHV strains to influence specific activities of the host cells 
that they infect. Early reports indicate that A59 infection en- 
hances the expression of MHC class I molecules in primary 
cultures of murine glial cells (33) and that the enhancement 
also occurs in the brain after i.c. infection in C57B1/6 mice 
(34). Since class I molecules play a key role in the interaction 
between infected target  cells and CD8 + cytotoxic T  cells 
(CTL; 35, 36), any change in their expression  after virus in- 
fection has potential implications for the outcome of the in- 
fection. Cells in the CNS generally express little, if any, con- 
stitutive class  I  antigen in vivo,  but  astrocytes have been 
consistently reported to express both class I and class II an- 
tigens in vitro after the addition of IFN-3' and/or TNF-ot 
to the culture medium (37-42). Several reports indicate that 
astrocytes are capable of acting as antigen-presenting cells for 
in vitro antigen- or a11ospecific CD4 § and CD8 § T cell re- 
sponses (43,  44),  which suggests that they also have poten- 
tial to participate in immune responses occurring within the 
confines of the CNS. Since clearance of infectious JHMV from 
the  CNS  requires  class I-restricted  CD8 +  T  cells  (11, 
45-47),  it is of particular interest to characterize  the effect 
of MHV infection on class I expression in one of its principal 
cellular targets. 
In this communication, we have examined the ability of 
a panel of MHV strains  to induce class I expression  in cul- 
tures enriched at least 95% for astrocytes.  The data indicate 
that class I expression  occurred in response  to all the MHV 
strains  tested except JHMV and virus strains  derived from 
JHMV. Additional studies show that class I expression  re- 
quires  the presence  of infectious virus. Finally, the testing 
of A59/JHMV recombinant viral strains  suggests that the 
class I-inducing activity resides in the 3' end of the A59 ge- 
nome, possibly in one of the genes encoding the structural 
proteins. 
Materials  and Methods 
Primary Astrocyte Cultures.  Astrocytes  were isolated  from mixed 
glial cell cultures prepared from the brains of newborn C57B1/6 
mice (Bantin and Kingman, Fremont, CA) at postnatal day 0-3 
according to McCarthy and deVellis (48). Briefly, single cell sus- 
pensions were prepared from cerebri dissected free of brain stems 
and cerebelli, plated at 3-5 brains per T-75 flask and allowed to 
grow to confluence at 12-15 d in vitro. Culture medium consisted 
of DMEM/Ham's F12 (1:1; JRH Biosciences, Lenexa, KS) sup- 
plemented with 10% FCS (Gemini Bioproducts, Inc., Calabasas, 
CA),  15 mM Hepes, 2.5 mM t-glutamine, and penicillin/strep- 
tomycin (100 U/ml-100 ~g/ml). At confluence the cultures were 
mechanically shaken to dislodge microglia and oligodendroglia, 
resulting in preparations enriched 95% or greater for cells staining 
for glial fibrillary  acidic protein (GFAP). Immunoperoxidase  or im- 
munofluorescent staining (described below) revealed that the cell 
preparations contained ,-2-4% of cells of microglia/macrophage 
lineage, expressing F4/80, T-200, the mouse equivalent of human 
common leukocyte  antigen (CD45), and/or Mac-1 surface  markers. 
Coronavirus Strains and Infection.  Table 1 presents a summary 
of the MHV strains used and the principal types of diseases they 
cause in mice. The derivation, propagation, and sources of MHV- 
A-59, JHM-DL, JHM-DS, MHV-1, MHV-2, MHV-3, MHV-D, 
MHV-K, and MHV-Nuu have been described (12). The neutrali- 
zation-resistant MHV-4 strains 2.2-V-1 and 2.2/7.2-V-2 (28, 29) were 
the  kind  gift of Dr. John Fleming (University of Wisconsin, 
Madison, WI). The development and properties of JHM-X and 
the JHM/A59 recombinant MHV strains have  been reviewed (49). 
All virus strains were propagated using the murine astrocytoma 
DBT as previously described (6). Virus titers were determined for 
each virus preparation using DBT as indicator cells. 
Infectious Center Assays.  The number of  infected astrocytes  was 
determined on day 3 p.i. to provide  a measure  of  the relative  efficiency 
of infection by several MHV strains. Briefly,  astrocytes  were tryp- 
sinized into single cell suspensions and, after washing, were plated 
on DBT cell monolayers  at 0.1, 1, 10, 100, and 1,000 cells/60 mm 
petri dish. Cells were allowed to attach for 1 h at 37~  before the 
addition of agarose at 0.6%  in IkPMI 1640 supplemented with 
2%  heat-inactivated FCS, 20 mM Hepes, and penicillin/strep- 
tomycin. Plaques were counted after 48 h incubation at 37~ 
Virus Inactivation by Exposure to Ultraviolet Light.  Inactivation 
of virus was accomplished  by exposure to UV light under a UVP 
transilluminator (UVP Inc.,; San Gabriel, CA) at 7 mW/cm  Z for 
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2.2-V-1  (MHV-4) 








Lethal encephalitis,  demyelination 
Demyelination,  encephalitis 
Lethal encephalitis,  demyelination 
Nonlethal  demyelination 
Nonpathogenic  CNS infection 
Lethal encephalitis,  demyelination, 
hepatitis 
Nonpathogenic enteric infection 
Nonlethal  myeloproliferative disease, 
hepatitis 
Nonlethal  hepatitis,  enteritis 
Nonlethal mild hepatitis 
Lethal hepatitis 
Lethal hepatitis,  choroidoependymitis 
30 min. Virus inactivation was confirmed as lack of virus infec- 
tivity in plaque assays using DBT cells. 
Antibodies.  To identify class I molecules in primary astrocyte 
cultures, mAbs specific for K b (AF6.88.5.3),  DbL  d (28-14-8S),  K d 
(SF1-1.1.1), and D e (34-5-8S)  were obtained from the American 
Type Culture Collection (ATCC HB 158,  HB 27,  HB 159, and 
FIB 102, respectively; Rockville, MD) and used as tissue culture 
supernatants.  Optimal antibody concentrations were determined 
by ILIA or FACS  |  (Becton Dickinson & Co., Mountain View, CA) 
analyses in preliminary experiments using either astrocytes or lym- 
phocytes from the appropriate haplotype. The percentage of GFAP- 
positive astrocytes was determined in the enriched cultures using 
polyclonal anti-GFAP antibody (rabbit antibovine GFAP; Dakopatts, 
Glostrup, Denmark). Cells of macrophage/monocyte lineage were 
identified using a mixture of mAb specific for Mac-1 (hybridoma 
M1/70.15,  ATCC TIB 128), F4/80 (ATCC HB 198), and T-200, 
which  recognizes  all  cells  of bone  marrow  origin  (hybridoma 
M1/9.3.4HL.2, ATCC TIB 122). The possible presence of oligoden- 
drocytes was identified using polyclonal rabbit antigalactocerebro- 
side (Gal C, a gift from M. Smith, Stanford University, Stanford, 
CA). Finally, viral antigen was identified using J.3.3, a mAb specific 
for the N protein of JHMV that crossreacts with all of the MHV 
strains used in this study (12). 
RtA.  The expression of class I molecules was measured in as- 
trocytes cultured in flat-bottomed 96-well plates at a density of 10  4 
cells/well and infected with various virus strains at a multiplicity 
of infection (m.o.i.) of 1-2. Mock infected cells served as controls. 
On day 3 or 5 p.i., cells were washed twice using a wash buffer 
of 0.3%  BSA in 0.1 M  PBS before the addition of 50/A of the 
appropriate mAbs in triplicate. After a 60 rain incubation at room 
temperature, cells were washed three times, followed by the addi- 
tion  of 20,000  cpm/well of 12SI-labeled protein A  (30  /~Ci//zg; 
ICN Biomedicals, Costa Mesa, CA). At the end of a second 60- 
min incubation,  cells were extensively washed in PBS to remove 
unbound radiolabeled protein A and detached with 0.5% trypsin- 
0.2% EDTA (JRH Biosciences).  Data are presented as cpm bound 
radioactivity +  SD, or percent increase in class I expression in in- 
fected cells compared with that in uninfected controls, corrected 
for background binding in the absence of antibody. A result was 
considered positive when the percent increase  in expression was 
100% or greater. Nonspecific staining was identified by the inclu- 
sion of Kd-specific mAb SF1-1.1.1. In some experiments, superna- 
tants from infected cells were substituted for virus and RIA per- 
formed to detect class  I 3 d  later. 
Immunoperoxidase and Immunofluorescent Staining.  Cell pheno- 
types and the number of infected ceUs were determined by im- 
munoperoxidase staining in astrocytes cultured in tissue culture 
chamber slides. Avidin-biotin immunoperoxidase staining kits (Vec- 
tastain; Vector Laboratories Inc., Burlingame, CA) were used ac- 
cording to the manufacturer's instructions as previously described 
(21). Cells were infected with virus 1 d after plating and fixed on 
day 3 or 5 p.i. in acetone/methanol (1:1). The number of positively 
stained cells in each well was determined in three fields/well at a 
magnification of 20x  and reported as the percentage of the number 
of total cells in the same fields. Background staining was deter- 
mined in cells  stained in the absence of primary antibody. 
Class I expression was also evaluated by FACS  |  using an indirect 
immunoftuorescent staining procedure. Briefly, single cell suspen- 
sions of astrocytes were adjusted  to 105 to 106 cells/tube before the 
addition of class 1-specific primary antibodies. FITC-labeled goat 
anti-mouse IgG F(ab)2 was used as secondary antibody (Jackson 
ImmunoResearch Laboratories,  West Grove, PA). Fluorescence data 
were collected  on 3  x  103 to 104 viable cells, indicated  by forward 
light scatter intensity, using a FACStar  cell sorter (Becton Dick- 
inson & Co.). Again, background fluorescence was determined in 
cells stained in the absence  of primary antibody. 
Detection oflnterferons.  The possible presence oflFN in the su- 
pernatants of infected astrocytes was determined by bioassay in a 
vesicular stomatitis virus (VSV) neutralization assay using vital dye 
uptake as a spectrophotometrically measured endpoint in L929 cells 
(50, 51). Supernatants  were collected from infected and control unin- 
fected astrocytes on day 3 and 7 p.i., UV irradiated, and added in 
triplicate to L929 cells plated at  10  s cells/well in 96-well plates. 
After a 24-h incubation at 37~  and 7% CO2, supernatants were 
aspirated and cells infected with VSV (Indiana strain) at approxi- 
mately 10 tissue culture infectious doses (TCIDs0)/well. Control 
wells included uninfected L929 cells (cell control) and VSV-infected 
L929 cells cultured in the absence of interferon (virus control). At 
24-36 h p.i., when CPE was maximum in the control wells, cells 
were stained for 2 h at 37~  with 0.004% neutral red. They were 
then lysed to release retained dye using 0.01 M HC1 in 30% eth- 
anol, and ODs measured at 540 nm in an automated microELISA 
reader (Dynatech Laboratories, Inc., Chantilly, VA). IFN concen- 
trations were deduced by comparison of sample ODs with those 
of standard concentrations of recombinant mouse IFN-3' (Genzyme 
Corp., Cambridge, MA) and murine IFN-c~//3 (Lee Biomolecular, 
San Diego,  CA). 
Immunoneutralization was also used to identify the possible pres- 
ence of IFN in UV-irradiated supernatants of A59qnfected astro- 
cytes.  For this purpose, rat monoclonal anti-mouse IFN-3' anti- 
body (hybridoma R4-6A2;  ATCC HB 170) or rabbit polyclonal 
anti-mouse IFN-a/3 (Lee Biomolecular) was added to the astro- 
cytes before the addition of A59, and class I expression measured 
by RIA on day 3 p.i.  Anti-IFN-3' (20-60/zg/ml)  completely in- 
hibited the protective activity of 10 U/ml of recombinant mouse 
IFN-3', whereas 10-30 U/ml anti-IFN-a/r  effective in neu- 
tralizing 20 U/ml purified mouse IFN-c~//~. 
Detection of TNE  TNF  activity was measured in a cytotox- 
icity assay using actinomycin D-treated L929 fibroblasts as targets, 
again with vital dye uptake as a spectrophotometric endpoint. Serial 
2-fold dilutions of UV-irradiated supernatants, or 10-fold dilutions 
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were added to L929 monolayers in 96-well plates in the presence 
of actinomycin D (8 #g/ml; Sigma Chemical Co., St. Louis, MO). 
After an  18-h incubation  at  37~  7%  CO2,  neutral  red  was 
added as described for the IFN assay, and OD read at 540 nm. 
Results 
MHV-A59,  but Not JHM-DL,  induces MHC Class I Ex- 
pression in Primary Cultures of Murine Astrocytes.  To inves- 
tigate the effects of coronavirus infection on MHC class I 
expression in primary astrocytes~ cultures were routinely used 
at 20-30 d  in vitro, or 6-12 d  after mechanical shaking to 
remove oligodendrocytes and microglia.  Fig.  1 shows that 
A59 induced abundant class I expression in astrocytes, mea- 
sured by RIA using the Kb-specific mAb AF6.88.5.3. Class 
I expression was routinely measured on days 3 and 5 p.i. after 
infection at an m.o.i, of 1, though it was detectable within 
24-48 h  p.i.  K b was preferentially expressed over D b after 
A59 infection. This was not due to a lack of inducibility of 
the D b molecule, since both K b and D b were expressed spon- 
taneously with time in culture, and also in response to 100 
U/ml of IFN-3/(data not shown). Under these conditions, 
K b was expressed earlier than D b, and usually at significantly 
higher levels. In infected astrocytes, the class I-inducing ac- 
tivity of A59 was consistently 30-50%  more potent  than 
the single dose of 100 U/ml of IFN-3' (Fig. 2). Finally, FACS  | 
analyses revealed that K b was expressed on '~50% of the as- 
trocytes in  the infected cultures. 
By contrast, the large plaque morphology variant of  JHMV 
designated JHM-DL did not  stimulate class I  at  all,  or at 
best, stimulated minimal expression at 10-20% over that ob- 
served in uninfected ceUs (Fig.  1 and 2). These data indicate 
that the ability to induce class I expression is not a general 
property of MHV  strains. 
Figure  1.  MHC class I is induced  in primary  murine  astrocytes  by A59, 
but not JHM-DL. Class I expression  was measured on days 3 and 5 p.i. 
using mAb specific  for K  b, D  b, and D  a as described in Materials and 
Methods. Data are represented  as mean cpm _+ SD of triplicate determi- 
nations. 
Figure 2.  MHC class I (K  b) induction in primary astrocytes  by A59 
relative to that of IFN-% Recombinant IFN-3' was added to astrocytes 
for 48 h at 100 U/m1 before  R.IA at days  3 and 5 p.i. Data represent  mean 
cpm  _+  SD of triplicate determinations. 
Virus Strains Related to or Derived  from JHM-DL Do Not 
Stimulate Class I Expression.  To determine whether the lack 
of ability to stimulate class I expression in astrocytes is specific 
for JHMV,  a panel of virus strains derived from wild-type 
JHMV or from JHM-DL were tested. The results indicate 
that none of the JHMV strains isolated in our laboratories 
stimulated class I (Table 2). In addition, JHM-X, which was 
derived from JHMV passage  in Japan and has been shown 
to have extensive deletions in the S gene (11), did not affect 
dass I  expression. By contrast,  all of the viral strains in a 
panel of  more hepatotropic isolates of MHV, including MHV- 
NuU, MHV-K, MHV-D, MHV-1, MHV-2, and MHV-3, 
were effective stimulators of class I expression. The magni- 
tude of stimulation, expressed as percent change relative to 
uninfected cells, varied with the individual viral strain 2-10- 
fold over that in uninfected cells. A59 and MHV-2 were the 
most potent inducers of the class I K b molecule, and both 
inconsistently  induced  a  low-level  expression  of  D b.  It 
should be mentioned that the Kd-specific mAb SF1-1.1.1 oc- 
casionally yielded a low level of nonspecific binding;  how- 
ever, it was significantly lower than the specific binding ob- 
served with  the Kb-specific  antibody. 
Studies with Recombinant A59/JHMV Strains Map the Genes 
Responsible_for Class I Expression to the 3' End of  the Genom~  To 
determine whether a specific A59 gene or genes are respon- 
sible for the class I-inducing activity, a panel of recombinant 
viruses between A59 and JHMV that retain various portions 
of A59 sequences were tested. The results,  represented in Fig. 
3 and summarized in Fig. 4, indicate that all strains that re- 
tain A59 sequences at the 3' end of the recombinant genome 
were potent class I inducers. Thus, CA13 and CA43, which 
retain •30-40%  JHMV sequences at the 3' end, were com- 
pletely devoid of class I-inducing activity. This end of the 
MHV genome contains  the genes encoding the structural 
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Experiment  Virus  strain  K  b  D b  Dd/K  d 
1  JHM-DL  10  9  0/-~ 
JHM-DS  7  10  0/- 
JHM-X  0  25  0/- 
2.2-V-1  0  0  0/- 
2.2/7.2-V-2  0  0  0/- 
A59  322  0  0/- 
2  JHM-DL  7  29  0/- 
A59  958  110  0/- 
A59H  1,042  0  0/- 
MHV-2  822  0  0/- 
3  A59  359  -  -/0 
MHV-NuU  331  -  -/65 
MHV-K  281  -  -/13 
MHV-D  257  -  -/93 
MHV-1  258  -  -/0 
MHV-3  369  -  -/40 
4  JHM-DL  17  11  0/- 
A59H  786  8  0/- 
MHV-2  955  94  0/- 
* MHC Class I expression  was measured  by RIA on day 3 p.i. (m.o.i. =  1) using mAbs AF6.88.5.3 (Kb), 28-14-8S (Db), 34-5-8S (Dd), and SFI-I.I.1 
(Kd). Values are expressed  as percent  change relative  to uninfected  ceUs stained with the indicated mAb. Positive  results were defined  as an increase 
in class I expression  greater than or equal to 100% over  that observed  in uninfected  cells. Descriptions of assay procedures  are included  in Materials 
and Methods. 
* (-) Not tested. 
proteins S, M, and N  in addition to two nonstructural pro- 
teins, which suggests that the class I-inducing activity re- 
sides in one of these proteins. Often, though not exclusively, 
the most potent inducers of class I were strains that retain 
the highest percentage of A59 sequences at the 3' end, while 
those retaining the least A59 character, or exhibiting more 
than one crossover site for recombination, were significantly 
less potent. In addition, it was observed in three out of four 
experiments that RL1 was •50%  less potent than EL3, as 
illustrated in Fig. 3 B. EL3 retains slightly more A59 sequences 
in the S gene than RL1. This observation suggests that class 
I-inducing activity may involve S. However, it was not pos- 
sible to attribute the class I-stimulating activity to an in- 
dividual gene or gene product, since none of the recombinants 
had crossover sites that sufficiently isolated individual A59 
from JHMV genes.  However, it was clear that ifJHMV se- 
quences were retained at the 3' end, class 1-inducing activity 
was abolished, and that 5' retention of A59 sequences did 
not  salvage  it. 
The Ability_ of MHV  to Induce Class I Is Not Dependent on 
Replication Efficiency.  In our laboratory, A59 grows to higher 
titer in vitro than the JHMV strains in DBT cells, often ex- 
ceeding JHMV growth 10-20-fold. In addition, recombinant 
viruses containing A59 leader predominate over those con- 
taining JHMV leader, suggesting that A59 leader provides 
a growth advantage (52). Thus, it was important to deter- 
mine whether the lack of class I inducing activity by JHMV 
was due to poor replication efficiency in primary astrocytes. 
For this purpose, the number of astrocytes staining for viral 
antigen was determined by immunoperoxidase staining, and 
the yield of infectious viral particles/cell was measured in in- 
fectious center assays. The data, presented in Table 3, indi- 
cate that on day 3 p.i., 53% of the JHM-DL-infected astro- 
cytes were positive for viral antigen, compared with 45% 
of cells infected with A59.  In addition, cells infected with 
the recombinant virus CA13, which retains 3' JHMV and 
5' A59 sequences and does not stimulate class I expression, 
showed 48% antigen positive staining.  Cells infected with 
CA13 produced the highest level of infectious virus at 0.51 
plaques/cell, in spite of its inability to stimulate class I ex- 
pression (Table 3). By contrast, EL3, which was an effective 
class I inducer, replicated at relatively low efficiency at 0.08 
plaques/cell. Thus, class 1-inducing activity was not a func- 
tion of the ability of the virus to infect or replicate in pri- 
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mary astrocytes, nor did it appear to depend on the presence 
of A59  leader. 
Class 1-inducing Activity Is a Direct Consequence of A59 Infec- 
tion.  It  has been  reported  that  class  I  induction  in A59- 
infected glial cell cultures is not a direct consequence of in- 
fection, but is instead due to the release of a soluble factor 
into the medium that requires continual virus production (33, 
53, 54).  The presence of a non-IFN-like soluble factor was 
demonstrated in supernatants  from A59-infected glial cells 
that had been exposed to UV light  to inactivate the virus. 
Similarly, our data show that UV-inactivated A59 and A59- 
like recombinant coronavirus strains are not able to induce 
class I activity in purified astrocytes (Table 4). Virus inactiva- 
tion in the UV-treated virus preparations was confirmed by 
plaque assay using DBT cells (data  not  shown).  However, 
class I-inducing activity was not detected in the supernatants 
collected on days 3 and  7 p.i.  from A59-infected astrocytes 
and exposed to UV light to inactivate the virus (Fig. 5), while 
supernatants  that were not exposed to UV light and thus, 
contained infectious virus, were able to induce class I. Induc- 
tion was not inhibited by the addition of antibodies specific 
for IFN-'y or IFN-ot/~  to the astrocytes before A59 infec- 
tion (Table 5). Finally, there was no evidence of the presence 
of TNF-ot in UV-treated  supernatants  of A59-infected as- 
trocytes (data not  shown).  These data suggest  that  class  I 
induction is a direct consequence of A59 infection itself, and 
does not occur indirectly as a result of the release of a soluble 
class  I  inducer into  the  astrocyte medium. 
Figure 3.  MHC class I (K  b) induction in primary astrocytes infected 
by A59 and recombinant A59/JHMV coronavirus strains. Data represent 
mean _+ SD of triplicate determinations. Data are also included for unin- 
fected astrocytes exposed to IFN-y (100 U/ml) for 48 h before assay on 
day 3 p.i. A and B are two experiments that are representative of four 
experiments yielding similar results. 
Discussion 
In this communication, we report that the ability of A59 
to stimulate MHC class I expression during acute infection 
in primary murine astrocytes, previously observed by Suzumura 
et al. (33, 53, 54), is not an inherent property of MHV strains. 
It is interesting to note that the strains that did not stimulate 
class I are derivatives of the highly neurotropic MHV-4,  or 
JHMV  strain,  whereas  most of the MHV  strains  that did 
are the more hepatotropic strains. However, class I-inducing 
Table  3.  Efficiency of Infection of Coronavirus Strains at 
3 dp.i. 
Percent  No. 
Virus  strain  cells infected*  plaques/cell* 
JHM-DL  53  0.20 
A59  45  0.19 
B1  40  0.18 
EL3  41  0.08 
RL1  42  0.14 
CA13  48  0.51 
* Determined by immunoperoxidase staining using an antibody specific 
for the nucleocapsid protein of JHMV. 
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Genetic structure  of the recombinant  A59/JHMV strains used. 
Class I-inducing ability is indicated for each strain. 
1018  Coronavirus  Induction of Class I MHC Expression Is Virus Strain Specific Table  4.  Induction of MHC Class I  by A59 and A59-1ike Recombinant Coronavirus Stains Requires Infectious Virus* 
Experiment  Virus  strain  K b  D b  D d 
A59  301  -  0 
A59 UV*  0  -  7 
A59  363  0  0 
A59  UV  8  2  0 
A59  4,091  0  0 
B1  2,544  0  0 
EL3  2,007  0  0 
R.L1  1,610  0  0 
B1  UV  0  0  0 
EL3  UV  0  0  0 
RL1  UV  0  0  0 
*  MHC class I was measured by RIA on day 3 p.i. (m.o.i.  =  1-2) using mAbs as defined in the legend for Fig.  1. Values are expressed  as percent 
change relative to uninfected cells stained with the appropriate mAb. 
* UV refers  to virus inactivated by exposure to ultraviolet light as described  in Materials and Methods. 
ability could not be exclusively attributed to selective tissue 
tropism, since A59 and MHV-3, which readily establish both 
CNS and hepatic infections, were potent inducers of class 
I expression in astrocytes. Lack of class I-inducing activity 
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Figure  5.  Relative to uninfected control cultures, MHC class I is not 
induced by UV-treated supernatants collected  on days 3 and 7 p.i.  from 
MHV-A59 infected astrocytes.  Supernatants were added to fresh astrocyte 
cultures and incubated for 3 d before RIA. Controls included superna- 
tants  from  MHV-A59-infected  cells  that  had  not  been  UV  treated. 
Nonspecific class I expression was measured using a Ka-specific mAb. Data 
are expressed  as mean cpm of triplicate determinations, with error bars 
indicating SDs. 
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in JHMV was also not due to poor replication efficiency in 
astrocytes, since JHMV infected the same percentage of cells 
and produced similar levels of infectious virus as the class 
I-inducing MHV strains (Table 3). Thus, some other MHV 
characteristic must be responsible for class I-inducing activity, 
or the lack thereof. 
Since the expression of class I genes is regulated by inter- 
ferons (55),  it seemed possible  that class I induction might 
Table  5.  Class I Induction by MHV-A59 Is Not Inhibited by 
Antibodies to IFNs* 
Virus 
Experiment  strain  Antibody  K b  D a 
1  JHM-DL  -  -  22  0 
MHV-A59  -  280  0 
MHV-A59  IFN-3~*  230  0 
MHV-A59  IFN-a/3 s  335  0 
2  JHM-DL  -  -  35  30 
MHV-A59  -  338  31 
MHV-A59  IFN-y II  282  0 
MHV-A59  IFN-a/3  338  4 
* Antibodies to IFNs were added before the addition of virus, and class 
I expression measured by RIA on day 3 p.i. Values are expressed  as per- 
cent change relative to uninfected cells stained with the appropriate mAb. 
* Anti-mouse IFN-3' added  at 60/~g/ml. 
S Anti-mouse IFN-cd3 added at  10 U/ml. 
II Anti-mouse IFN-~/added at 20/~g/ml. correlate with the ability of MHV strains to stimulate IFN 
production.  This possibility gains credibility from reports 
that JHMV is a notoriously poor inducer of interferon after 
in vitro (56) and in vivo (57) infection. However, Suzumura 
et al.  (53) did not detect IFNs in UV-treated supernatants 
from A59-infected mixed glial cells in spite of the presence 
of class I-inducing activity, and our findings indicate that 
A59-induced class I expression was not inhibited by antibodies 
to IFN-a/3 or -3' (Table 4). Unlike Suzumura et al.  (53), 
we did not find that class I-inducing activity was retained 
after UV-inactivation of A59 or the A59-1ike recombinant 
MHV strains (Table 4), and it was not detected in superna- 
rants from A59-infected astrocytes that were UV-treated to 
inactivate infectious virus (Table 5 and Fig.  5). In addition, 
we have recently found that class I expression is no longer 
observed when A59 replication is controlled by the culture 
of persistently infected astrocytes in the presence of MHV- 
specific polyclonal antiserum, in spite of the persistence of 
viral protein and RNA (58).  Overall, our data suggest that 
class I induction by MHV in astrocytes requires infectious 
virus and does not involve the secretion of a soluble factor. 
In this respect, it is interesting to note that the class I-in- 
ducing activity originally reported by Suzumura et al. (33, 
53) was also dependent on continuous virus production in 
glial cell cultures prepared from the brains of infected mice 
(54).  However, it is possible that our lack of detection of 
class I-inducing activity in the supernatants could reflect cul- 
ture, or other technical conditions. 
Although it was not possible to attribute class I-inducing 
activity to a single gene or gene product using the A59/JHMV 
recombinant virus strains,  the data clearly indicate that class 
I-inducing activity maps to the 3' end of the A59 genome, 
which contains the genes encoding the primary structural 
proteins S, M, and N, and two poorly understood nonstruc- 
tural proteins.  However, there are some indications that S 
is the most likely candidate.  For example, recombinant strains 
which retain more A59 sequences in the S gene tended to 
be more potent than those retaining less A59, or moreJHMV 
character. In addition,  the S gene shows the greatest anti- 
genic divergence of the structural proteins between A59 and 
JHMV (12-16) and so might be more likely to exhibit differ- 
ences in activity. This possibility is supported by data indi- 
cating that A59 andJHMV differ considerably in their ability 
to cause receptor-independent fusion and syncytium forma- 
tion (59). In addition, preliminary data suggest that A59 and 
JHMV may show selective binding to the cellular receptors 
for MHV (60), which are members of the carcinoembryonic 
antigen (CEA) family of proteins (61). 
The mechanism by which A59,  MHV-3,  and the A59- 
like recombinant MHV strains induce class I expression in 
astrocytes is currently unknown. Massa et al. (62,  63) have 
shown that MHC class I promoter activity is upregulated 
in astrocytes treated with IFN-y and that the upregulation 
is associated with an increase in the binding activities of the 
MHC class I regulatory element (MHC-CRE) and the IFN 
consensus sequence (ICS). Whether or not these regulatory 
elements are engaged by A59 infection remains to be deter- 
mined. 
Perhaps one of the more interesting findings in these studies 
is the prevalence of K b expression over that of D b after MHV 
infection, and to a lesser extent, IFN-3" treatment. Differen- 
tial  modulation  of H-2K  and  H-2D  molecules has  been 
reported to follow in vitro JHMV infection in mouse brain 
endothelial cells, and the data indicate that the nature of the 
regulation was dependent on the mouse strain and did not 
necessarily correlate with susceptibility to JHMV-induced 
CNS disease (64).  Thus, K was decreased and D  increased 
in endothelial cells from susceptible BALB/c mice, but both 
were upregulated in susceptible B10.S and (BALB/c  x  SJL)F1 
and resistant SJL endothelial cells. Differential expression of 
K and D molecules has not always been observed after virus 
infection of neural cells; both K and D molecules appear to 
be equally enhanced by West Nile virus infection in astro- 
cytes from CBA/H mice (65), and the murine neuroblastoma 
C1300 does not show differential K and D expression when 
persistently infected with measles virus (66).  However, the 
possibility that differential modulation of class I molecules 
may be linked to CNS disease, or may be a marker of suscep- 
tibility to virus-induced CNS disease, is suggested by studies 
using Theiler's murine encephalomyelitis virus (TMEV; 67, 
68). After i.c. TMEV inoculation, resistant B10 mice showed 
minimal class I expression in the CNS that did not differ 
between K and D, whereas susceptible B10.Q and B10.RBQ 
mice showed a greater increase in D expression compared with 
that of K  (67). 
The inability of JHMV to stimulate class I expression in 
C57BL/6 astrocytes in the current studies was not reported 
for astrocytes from BALB/c, CXJ-8, SJL, and B10.S mice by 
Joseph et al. (69).  In these experiments, JHMV infection at 
an m.o.i, of 0.1 was followed by a two- to threefold increase 
in the expression of H-2K molecules, measured by FACS  | 
analyses, but astrocytes from C57BL/6 mice were not tested. 
The disparity in our findings may again reflect differences 
in the regulation of class I expression that are mouse strain 
specific. However, it is also possible  that the disparity may 
be due to the cellular composition of the astrocyte cultures 
used for infection. In their report, Joseph et al. (69), did not 
indicate whether or not they purified the astrocytes from mixed 
glial cell cultures. In our hands, mixed glial cells that have 
not been subjected to mechanical shaking for purification of 
astrocytes show up to 30% contamination by microglia, or 
cells staining for macrophage/monocyte surface antigens (data 
not shown). Microglial cells readily express class I molecules 
both in vivo and in vitro (70-72), and so might be expected 
to express class I after JHMV infection. The cultures used 
in our experiments routinely show 95%  or greater purity, 
containing 2-4% microglial cells, and "~50% express class 
I after A59 infection. Thus, class I expression in these cul- 
tures occurs primarily in astrocytes, with little, if any contri- 
bution by microglia. Finally, it should also be mentioned that 
class I expression in astrocytes, like that in endothelial cells, 
does not appear to be linked to susceptibility to JHMV-induced 
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cephalitis and demyelination in spite of their differences in 
class I inducibility after JHMV infection. In addition, astro- 
cytes from SJL mice express class I after JHMV infection in 
spite of being resistant  to CNS disease. 
The different effect of A59 and JHMV on class I expres- 
sion in astrocytes suggests that class I may play different roles 
in their pathogenesis.  As discussed by Maudsley et al. (73), 
the classical picture of MHC expression after virus infection 
is that of an increase that is most likely mediated by the re- 
lease  of IFNs by infiltrating  immune  cells,  and is thought 
to facilitate the ability of T  cells  to recognize the infected 
cells and control or eliminate the infection.  Unfortunately, 
clearance of virus from infected tissue by CTLs is often ac- 
companied by significant cellular destruction,  which is not 
well tolerated in tissues with limited regenerative capacity, 
especially the CNS. Thus, the ability of a virus to stimulate 
class I expression in host cells may facilitate a rapid CTL re- 
sponse that in turn accelerates  tissue destruction originally 
begun by virus-mediated cell lysis (74). This may be the case 
for A59 infection, since the A59 strains used in these experi- 
ments cause a severe encephalitis  after i.c.  inoculation  that 
begins on day 4 p.i., and results in death of the majority of 
infected mice by day 6-7 p.i. (our unpublished data). How- 
ever, it is not known if the infiltration  of T  cells into the 
CNS after i.c. A59 infection is associated with the onset of 
encephalitis. By contrast, JHMV causes a similar clinical dis- 
ease, but the onset of encephalitis is delayed in comparison 
with that of A59, beginning on day 6-7 p.i. (21). Death occurs 
on day 9-11 at a similar incidence. The onset of encephalitis 
coincides with the appearance of immune cells in the CNS, 
which, after JHM-DS infection, peaks on days 7-9 p.i.  (75). 
It is possible that class I expression is upregulated at this time 
by the secretion of interferon by the infiltrating immune cells, 
facilitating JHMV-specific, CTL-mediated tissue destruction. 
Thus, the difference in the ability of  JHMV and A59 to stimu- 
late class I expression in astrocytes may contribute to the speed 
of disease progression in the CNS. It is interesting  to note 
that Fazakerley et al. (25) reported that the JHMV variant, 
V5A13.1,  is neuroattenuated relative to parental JHMV by 
its slower rate of spread in the CNS of BALB/c mice. Variant 
V5A13.1 differs from parental JHMV by the deletion of 142 
amino acids in one of the subunits of the S protein (16, 76), 
suggesting that S plays an important role in the rate of virus 
spread in the CNS. In this respect, it would be of interest 
to test the ability of neuroattenuated A59 strains to stimu- 
late class  I  expression in astrocytes. 
In conclusion, we present data indicating that significant 
differences exist among MHV strains in their ability to stimu- 
late class I expression in murine  astrocytes, and that  these 
differences may contribute to their ability to cause CNS dis- 
ease. Since class I expression has been reported on astrocytes 
in the brains of MS patients (77), the data have implications 
for understanding the role of class I in human CNS disease. 
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